Mutations of mitotic checkpoint genes in human cancers

Nature

Volumn 392, Issue 6673, 1998, Pages 300-303

  Cahill, Daniel P ^a   Lengauer, Christoph ^a   Yu, Jian ^a   Riggins, Gregory J ^a   Willson, James K V ^b   Markowitz, Sanford D ^b   Kinzler, Kenneth W ^a   Vogelstein, Bert ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DEMECOLCINE; DNA; NOCODAZOLE;

ARTICLE; CANCER CELL CULTURE; CARCINOMA IN SITU; CELL CYCLE; CHROMOSOME NUMBER; COLORECTAL CANCER; CONTROLLED STUDY; DNA SEQUENCE; GENE CONTROL; GENE MUTATION; HUMAN; HUMAN CELL; MITOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; ANEUPLOIDY; ANTINEOPLASTIC AGENTS; CELL CYCLE; CLONING, MOLECULAR; COLORECTAL NEOPLASMS; DEMECOLCINE; HUMANS; MITOSIS; MITOTIC INDEX; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASMS; NOCODAZOLE; PROTEIN KINASES; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0032546360     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/32688     Document Type: Article

References (29)

1. Boveri, T. Zur Frage der Entstehung maligner Tumoren vol. 1 (Gustav Fischer, Jena, 1914).
2. Loeb, L. A. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res. 51, 3075-3079 (1991).
3. Hartvell, L. Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells Cell 71, 543-546 (1992).
4. Perucho, M. Cancer of the microsatellite mutator phenotype. Biol. Chem. 377, 675-684 (1996).
5. Modrich, P. Strand-specific mismatch repair in mammalian cells. J. Biol. Chem. 272, 24727-24730 (1997).
6. Kulodner, R. D. Mismatch repair - mechanisms and relationship to cancer susceptibility. Trends Biochem. Sci. 20, 397-401 (1995).
7. Kinzler, K. W. & Vogelstein, B. Lessons from hereditary colon cancer. Cell 87, 159-170 (1996).
8. Lengauer, C., Kinzler, K. W. & Vogelstein, B. Genetic instability in colorectal cancers. Nature 386, 623-627 (1997).
9. Strand, M., Prolla, T. A., Liskay, R. M. & Petes, T. D. Destabilization of tracts of simple repetitive DNA in yeast by mutations affecting DNA mismatch repair. Nature 365, 274-276 (1993).
10. Murray, A. W. The genetics of cell cycle checkpoints. Curr. Opin. Genet. Dev. 5, 5-11 (1995).
11. Nasmyth, K. At the heart of the budding yeast cell cycle. Trends Genet. 12, 405-412 (1996).
12. Paulovich, A. G., Toczyski, D. P. & Hartwell, L. H. When checkpoints fail. Cell 88, 315-321 (1997).
13. Nicklas, R. B. How cells get the right chromosomes. Science 275, 632-637 (1997).
14. Li, R. & Murray, A. W. Feedback control of mitosis in budding yeast. Cell 66, 519-531 (1991).
15. Roberts, B. T., Farr, K. A. & Hoyt, M. A. The Saccharomyces cerevisiae checkpoint gene BUB1 encodes a novel protein kinase. Mol. Cell Biol. 14, 8282-8291 (1994).
16. Hardwick,G., Weiss, E., Luca, F. C., Winey, M. & Murray, A. W. Activation of the budding yeast spindle assembly checkpoint without mitotic spindle disruption. Science 273, 953-956 (1996).
17. Pangilinan, F. & Spencer, F. Abnormal kinetochore structure activates the spindle assembly checkpoint in budding yeast. Mol. Biol. Cell. 7, 1195-1208 (1996).
18. Taylor, S. S. & McKeon, F. Kinetochore localization of murine Bub 1 is required for normal mitotic tuning and checkpoint response to spindle damage. Cell 89, 727-735 (1997).
19. Hanks, S. K. & Quinn, A. M. Protein kinase catalytic domain sequence database: identification of conserved features of primary structure and Classification of family members. Methods Enzymol 200, 38-62 (1991).
20. Li, Y. & Benezra, R. Identification of a human mitotic checkpoint gene: hsMAD2. Science 274, 246-248 (1996).
21. Hartwell, L. H., Szankasi, P., Roberts, C. J., Murray, A. W. & Friend, S. H. Integrating genetic approaches into the discovery of anticancer drugs. Science 278, 1064-1068 (1997).
22. Waldman, T., Lengauer, C., Kinzler, K. W. & Vogelstein, B. Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature 381, 713-716 (1996).
23. Polyak, K., Waldman, T., He, T.-C., Kinzler, K. W. & Vogelstein, B. Genetic determinants of p53 induced apoptosis and growth arrest. Genes Dev. 10, 1945-1952 (1996).
24. Liu, B. et al. Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nature Genet. 9, 48-55 (1995).
25. Lengauer, C. et al. Large-scale isolation of human 1p36-specific P1 clones and their use for fluorescence in situ hybridization. Genet. Anal. Tech. Appl. 11, 140-147(1994).
26. Parsons, R. et al. Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer. Cancer Res. 55, 5548-5550 (1995).
27. Riggins, G. J., Kinzler, K. W., Vogelstein, B. & Thiagalingam, S. Frequency of Smad gene mutations in human cancers. Cancer Res. 57, 2578-2580 (1997).
28. Jen, J. et al. Allelic loss of chromosome 18q and prognosis in colorectal cancer N. Engl. J. Med. 331, 213-221 (1994).
29. Pangilinan, F. et al. Mammalian BUB1 protein kinases: map positions and in vivo expression. Genomics 46, 379-388 (1997).